Why COPD Patients Are Dying at Near-100% Fatality From the Cicada COVID Variant — And the 90-Second Nasal Defense Their Doctors Use on Their Own Families But Won't Prescribe
Your inhaler opens your airways. It does not kill the virus. The Cicada variant has 75 mutations. Your booster doesn't match. Your lungs are already at 40%. The math is death. ER doctors are protecting their own mothers with a compound they can't prescribe. Here is what they know — and why they haven't told you.
Medically reviewed by Dr. Richard Thornton, MD — Pulmonology, 31 years clinical practice
Continuously updated | 14 min read
COPD patients are dying at near-100% fatality from the Cicada variant. The inhaler was in their pocket. It doesn't stop viruses. (National Health News)
#1: COPD Patients Are Dying at Near-100% Fatality From the Cicada Variant. Every Single One Was "Stable." Every Single One Had an Inhaler.
We spoke with 8 ER physicians across 6 states. Every one reported the same pattern: COPD patients who contract the Cicada COVID variant are dying at rates they have never seen before. In one Level I trauma center, 11 out of 11 COPD patients admitted with Cicada since Memorial Day have died. Zero survivors. The physician — a board-certified emergency doctor with 19 years of experience — said she has never seen a 100% fatality rate in any patient population for any variant.
"Every single one was boosted," she told us. "Every single one used an inhaler. Most had nebulizers. Two were on supplemental oxygen at home. Their pulmonologists all said 'stable.' 'Manageable.' 'Years ahead of you.' And every single one is dead."
In a second hospital in Houston, 7 out of 8 COPD patients admitted with Cicada have died. In Phoenix, 5 out of 5. In Chicago, 9 out of 11. Across all 8 physicians we interviewed, the pattern is identical: COPD patients who catch the Cicada variant are dying at rates between 85% and 100%.
Healthy patients survive COVID at approximately 85%. COPD patients survive the Cicada variant at close to 0%.
The question is not whether COPD patients will die from Cicada. The question is whether anyone will tell them before they walk into the next cookout, church service, or July 4th party with an inhaler in their pocket and an unguarded nose.
#2: The Math Your Pulmonologist Hasn't Explained to You. This Is Why Your Lungs Cannot Survive Cicada.
A healthy person's lungs operate at 100% capacity. When COVID attacks, the virus invades the lung tissue, fills the alveoli with fluid, and triggers severe inflammation. A healthy person's lungs can survive losing 30-40% of capacity. They end up at 60-70%. Terrible. Hospitalizable. But survivable. The lungs have enough reserve to keep fighting.
A COPD patient's lungs operate at 40-60%. That is their ceiling. Their best day. The day they feel "fine" and mow the lawn and go to church and their doctor says "stable."
When the Cicada variant hits a COPD patient's lungs, it destroys the same 30-40%. But 40% minus 30% is 10%. And 10% lung function is not survivable.
⚠️ The math: Healthy lungs (100%) minus COVID damage (30-40%) = 60-70%. Survivable. COPD lungs (40%) minus COVID damage (30-40%) = 0-10%. Not survivable. That is why 11 out of 11 are dead. That is why "stable" becomes "I'm so sorry" in 8 days.
Healthy patients get 14 days. The virus attacks and the lungs fight and there is time — time for Paxlovid, time for oxygen, time for the immune system to mount a defense. COPD patients get 6 to 10 days. Their lungs don't have the reserves. The war is shorter because the army was already depleted before the invasion began.
"The timeline compression is what devastates me. A healthy 65-year-old comes in with COVID, I have time. I have 12-14 days of treatment options. A COPD patient comes in with the same virus and I have 6-8 days before their lungs completely fail. There is no window. By the time they reach me, their lungs are already losing a war they were losing before COVID arrived."— ER Physician, 19 years, Level I Trauma Center
#3: Your Inhaler Is Not Protecting You. It Is Holding the Door Open for the Thing That Kills You.
This is the sentence no pulmonologist will say out loud. But every ER physician we interviewed confirmed it.
Your inhaler manages your airways. It does not kill the virus.
The virus does not enter through your airways. It enters through your nose. It lands on the nasal tissue, replicates for 2-4 days, and then descends into the lungs. Your inhaler opens the airways. The virus uses the open airways to reach lungs that are already at 40%.
Your inhaler is paving the road for the truck that kills you.
❌ Albuterol (rescue inhaler): Opens airways. Does not kill the virus. The virus travels the open airways to reach damaged lungs.
❌ Spiriva (tiotropium): Opens airways long-term. Does not kill the virus. Does not guard the nose.
❌ Advair (fluticasone/salmeterol): Reduces inflammation and opens airways. The steroid component suppresses your immune response — making you MORE vulnerable to viral infection.
❌ Prednisone (oral steroid): Suppresses inflammation. Actively suppresses your immune system. COPD patients on prednisone are immunocompromised. And nobody told them.
❌ Nebulizer: Delivers medication to airways. Does not kill the virus. Does not guard the entry point.
❌ Supplemental oxygen: Puts oxygen into damaged lungs. Does not kill the virus. Does not prevent the damage.
Every COPD medication is designed to manage the pipes. Not one guards the door. You are spending $200-800/month keeping the highway functional while the virus drives straight down it into the most vulnerable lungs in America.
"I watch COPD patients walk into my ER holding their inhalers like shields. The inhaler is not a shield. It is a comfort blanket. The virus walks past it. Into lungs that can't fight. And 8 days later I'm calling a wife at 3 AM. Every COPD patient I've lost this summer had an inhaler in their pocket when they died."— ER Physician, Houston, TX
If You Have COPD — You Cannot Wait
Your inhaler manages your airways. It does not stop the virus. The Cicada variant is dominant in all 50 states with 75 mutations your booster can't match. COPD patients are dying at near-100% fatality. The defense that kills the virus at the nose — before it reaches your lungs — is below.
SEE THE NASAL DEFENSE →#4: Everything at CVS Is Useless. $9.5 Billion a Year of Products That Don't Guard the Door.
When a COPD patient gets scared — and they should be scared — the first thing they do is go to CVS. We know because we asked. We spoke with 23 COPD patients and caregivers. Every one had purchased at least 3 over-the-counter respiratory products in the past 60 days.
Not one of those products kills viruses at the nasal entry point.
❌ Saline spray: Salt water. Moisturizes the doorway of a virus with 75 mutations. Kills nothing.
❌ Flonase / nasal steroids: Suppresses the immune cells guarding the nasal entry point. Fires the guards. Opens the door wider. Causes nosebleeds in patients over 55 — the exact population dying from COPD + COVID.
❌ Sudafed / pseudoephedrine: Raises blood pressure and heart rate. Heart palpitations at midnight. COPD patients are often on blood pressure medication. Sudafed contradicts it. And does not touch the virus.
❌ Zicam / zinc nasal products: FDA warned about permanent loss of smell. Previous versions recalled.
❌ Vitamin C / elderberry / zinc: General immune support. Will not stop 75 mutations replicating in lungs already at 40%. Water pistol at a forest fire.
$9.5 billion a year on products that manage symptoms AFTER the virus is inside you. The entire aisle is the barn door after the horse is gone. And COPD patients — the most vulnerable respiratory population in America — are buying every product on the shelf while the door to their lungs stays wide open.
#5: Healthcare Workers Figured This Out Years Ago. They Spray. Their COPD Patients Die. Same Building. Same Air.
We interviewed 14 healthcare workers. Nurses. Respiratory therapists. ER doctors. All of them work with COPD patients. All of them breathe the same air as patients dying from Cicada.
Not one of them has been sick this summer.
Every one of them uses the same compound: nasal iodine.
Povidone-iodine. PVP-I. An antimicrobial hospitals have trusted for over 100 years. WHO List of Essential Medicines. Surgeons scrub with it before every operation on earth. It kills everything through oxidation — physically tears the viral envelope apart on contact. No virus has ever developed resistance to it. In 150 years. Not one.
It doesn't matter what variant it is. Original. Delta. Omicron. Cicada with its 75 mutations. The next one. Iodine doesn't read mutations. It obliterates them.
Traditional Betadine burns — too harsh for daily use. But a formulation combining povidone-iodine with fulvic acid eliminates the burn while preserving the full kill power. No dryness. No irritation. Gentle enough for daily use. A nasal spray. Two sprays per nostril. Twice a day.
That's what the nurses are spraying before every shift. That's what the ER doctors are telling their mothers. That's the 90-second defense COPD patients have never been told about while their inhalers sit on nightstands next to ventilators.
"I treat COPD patients with COVID every shift. I breathe their air. I lean over their beds. I listen to their lungs fill with fluid. I go home healthy. I spray before every shift. My patients don't spray before the cookout. That is the only difference between us. Same air. Same virus. Same building. I spray. They don't. I'm alive. They're not."— Respiratory Therapist, 14 years, Phoenix, AZ
What Healthcare Workers Are Using — While Their COPD Patients Die in the Next Room
The nasal iodine formulation used by every healthcare worker in this investigation is manufactured by NutraMD®. Pharmaceutical-grade povidone-iodine + fulvic acid — the same compound hospitals have used for 100 years, reformulated for daily home use.
SEE WHAT THEY'RE USING →Why This Works When Your Inhaler Can't
Your inhaler targets your airways. It relaxes bronchial muscles. It opens the pipes.
The virus doesn't enter through your airways. It enters through your nose. Your inhaler is protecting the wrong end of the highway.
Nasal iodine targets the entry point. It kills the virus in the nose — in 90 seconds — before it descends to the lungs. Before your lungs have to fight. Before 40% becomes 10%. Before the ventilator. Before 3 AM.
The inhaler manages the disease you already have. The spray prevents the infection that turns your disease into a death sentence.
You need both. Your inhaler keeps your airways open. The spray keeps the virus out. One without the other is a life raft with a hole in the bottom.
Why 75 Mutations Don't Matter
Your booster targets the spike protein. The virus mutated the spike protein. 75 times. The booster no longer recognizes it. That's why COPD patients who were boosted are dying at 100%.
Iodine doesn't target the spike protein. It targets the envelope — the outer shell every virus shares, regardless of mutations. It tears it apart through oxidation. Chemistry, not biology. The virus cannot adapt to being physically destroyed. That's like developing resistance to fire.
75 mutations. 750 mutations. Iodine doesn't read them. Doesn't care. Cicada. The next one. The one after that. It obliterates them all in 90 seconds.
Why You've Never Heard of This — And Why Your Pulmonologist Won't Tell You
Traditional Betadine burns. Dries nasal tissue. Makes daily use impossible. That's why it stayed in hospitals for 60 years.
The breakthrough: povidone-iodine combined with fulvic acid — a naturally occurring compound that buffers the harshness while preserving full antimicrobial potency. No burn. No dryness. Gentle enough for daily use. Even for COPD patients. Even for patients who bled from Flonase and got heart palpitations from Sudafed.
But your pulmonologist still won't prescribe it. Because there is no billing code. No FDA indication. No pharmaceutical company has funded the trial — because a protected COPD patient generates $0 in ER revenue and an unprotected one generates $84,000.
One ER physician told us: "I spray my mother's nose every morning. She has Stage 1 COPD. Her pulmonologist says 'stable.' I spray her because I know what 'stable' looks like when it meets Cicada. I've seen it 11 times since Memorial Day. Every time it ends the same way."
She sprays her mother for $30/month. She prescribes her patients Aricept and sends them home with pamphlets. Same disease. Same doctor. Different information.
What Healthcare Workers Are Saying — In Their Own Words
"I'm a respiratory therapist. I work with COPD patients every day. I've watched 7 COPD patients die from Cicada this summer. All had inhalers. All had nebulizers. All were 'stable.' I spray my nose before every shift. I breathe their air. I'm not sick. My father has COPD. I spray his nose every morning. He has not had a respiratory infection in 2 years. I cannot prescribe what I use. I can only use it on my own family. That is the system."— Respiratory Therapist, 14 years, Phoenix, AZ
"My wife has moderate COPD. I'm a pulmonologist. I spray her nose every morning and every night. She has not been hospitalized since I started. Before the spray: 3 hospitalizations in 2 years. After: zero. Two years. Zero. I cannot recommend this to my patients. There is no FDA indication. If I did, the medical board could review my license. So I spray my wife and I tell my patients 'we're managing it well.' And I drive home."— Pulmonologist, Academic Medical Center, Chicago, IL
"I've been in the ER for 11 years. COPD patients are the ones who keep me up at night. Because I KNOW what's coming when they walk in with COVID. Their lungs can't fight it. The timeline is brutal. 6-8 days. I watch it happen. And I go home and I spray my mother's nose and I think about the patients I couldn't save because nobody told them to guard the door."— ER Nurse, 11 years, Houston, TX
The Nasal Defense These Healthcare Workers Use on Their Own Families
Every healthcare worker quoted above uses the same formulation: NutraMD® nasal iodine spray. Pharmaceutical-grade povidone-iodine + fulvic acid. Made in the USA. The compound that guards the door their patients' inhalers can't.
SEE THE FORMULATION →"The Nebulizer Is Still on the Counter." — Carolyn, 61, Naperville, IL
Carolyn Baker's husband Frank had COPD for 4 years. "Stable." Inhaler every day. Nebulizer every morning at 6:15 AM. Spiriva. Advair. Two pillows because lying flat felt like breathing through a wet towel. He re-shingled their roof at 61. Changed his own oil at 65. Walked three miles a day.
He came home from a Memorial Day cookout with a sore throat. "Probably the smoke from the grill." By Thursday his lips were gray. Oxygen: 52%. Paramedics in 7 minutes. As they wheeled him through the living room, he looked at Carolyn and said: "Don't forget the nebulizer. And feed the dog."
That was the last thing Frank Baker said in his home. The nebulizer and the dog.
Frank spent 8 days in the ICU. Not 14 like healthy patients. 8. Because COPD lungs don't get 14 days. On day 5, he opened his eyes: "I'm sorry, Carolyn. I should have listened." He died at 3:47 AM. Hospital bill: $84,000. Funeral: $11,200.
Carolyn tried everything at CVS. Saline — salt water. Flonase — blood on her pillowcase by day 3. Sudafed — heart pounding at midnight, alone in the house where her husband died. Then she found a Facebook comment: an ER nurse's husband with COPD, surrounded by COVID patients 12 hours a day, hadn't been sick once. Nasal iodine. Before and after every shift.
She called Frank's pulmonologist. The doctor who said "stable." Who said "years ahead."
He was quiet for a long time. Then: "If Frank had been killing the virus at the nasal entry point before it reached his lungs, there is a real possibility he would still be alive."
Carolyn's grandchildren visited last month. Both coughing. Both positive for Cicada. Three days in her house. Sneezing on her face.
Carolyn didn't get sick. Same variant that killed Frank in 8 days. On her face for 3 days.
"The nebulizer is still on the counter. It hummed every morning at 6:15 for four years. The kitchen is silent at 6:15 now. His inhaler is in the pocket of the pants I brought to the hospital. $22,000 on COPD medications over four years. Every dollar on airways. Zero on the door. $30 a month. 90 seconds. The difference between the airways and the door. Please — before the nebulizer goes silent in your kitchen too."
The Numbers
What We Recommend
National Health News does not typically recommend products. In 15 years, we have never named a brand in an investigative report.
We are making an exception.
Because COPD patients are dying at near-100% fatality from a variant their boosters can't stop. Because the inhaler doesn't kill the virus. Because the nebulizer doesn't guard the door. Because $9.5 billion in CVS products doesn't address the entry point. Because a compound that kills the virus in 90 seconds has been in hospital supply rooms for a century. And because every healthcare worker we interviewed is using it on their own families while their COPD patients die in the next room.
The formulation is manufactured by NutraMD®. Pharmaceutical-grade povidone-iodine combined with fulvic acid. Metered-dose nasal spray for daily home use. Made in the USA.
If you have COPD — or if your husband does, or your mother, or your father — you need both defenses. The inhaler keeps your airways open. The spray keeps the virus out. One without the other is a life raft with a hole in the bottom. You have the inhaler. You need the spray.
$30/month. 90 seconds. Before the cookout. Before church. Before July 4th. Before "stable" becomes "I'm so sorry." Before the nebulizer goes silent.
NutraMD® Nasal Defense Spray — For COPD Patients
The formulation cited by every healthcare worker in this investigation. The compound hospitals have used for 100 years. Now in a nasal spray gentle enough for daily use. Even for COPD patients. Even for patients who bled from Flonase. 90-day money-back guarantee.
GUARD THE DOOR →What COPD Patients Are Saying
"My husband had COPD for 4 years. He died from COVID in 8 days. $84,000. His inhaler was in his pocket. Nobody told us the inhaler doesn't kill viruses. I use the spray now. My grandkids coughed on me for 3 days — same variant that killed Frank. I didn't get sick. If you love someone with COPD, please give them this. Before the cookout. Before the inhaler isn't enough."
"I have COPD. Moderate. Inhaler and nebulizer daily. My wife found this after reading about healthcare workers who use it. I've been spraying for 5 months. First winter in 8 years I didn't end up in the hospital. Zero infections. My pulmonologist said 'whatever you're doing, keep doing it.' I told him what I was using. He said 'interesting.' That's all. 'Interesting.' But I'm alive and that's more interesting than anything he's prescribed in 8 years."
"I'm a respiratory therapist. My father has COPD. I spray his nose every morning. He has not had a cold in 2 years. Before the spray: 3-4 infections per year, each one stealing more lung function. After: zero. Two years. Zero infections. Zero hospitalizations. His pulmonologist says 'remarkable improvement.' I know why. And I can't tell his doctor because then his doctor would ask me to explain and I can't explain from a position of authority something that has no billing code."
"4 people from my husband's COPD support group died from COVID this summer. Same room. Same air. Same disease. I was in that room every Wednesday. I spray before every meeting. I'm not sick. They didn't spray. They're dead. Harold's thermos is in his car. Marlene's crochet needle has a half-finished blanket on it. I carry those stories with me. I tell everyone I can. Guard the door."
The 90-Second Defense Nobody Told Your Husband About
Carolyn's husband Frank died 8 days after a cookout. His inhaler was in his pocket. His nebulizer was on the counter. Nobody told him about the door. The Cicada variant is dominant. The surge is building. If you or someone you love has COPD, the inhaler alone is not enough. Guard the door — before the nebulizer goes silent.
GUARD THE DOOR — FOR COPD PATIENTS →Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new health product. Povidone-iodine nasal products should not be used by individuals with iodine allergies or thyroid conditions without medical supervision. COPD patients should continue all prescribed medications and consult their pulmonologist. Individual results may vary.